Results 1 to 10 of about 10,435 (209)
Snakebite epidemiology, outcomes and multi-cluster risk modelling in Eswatini [PDF]
BackgroundHalving snakebite morbidity and mortality by 2030 requires countries to develop both prevention and treatment strategies. The paucity of data on the global incidence and severity of snakebite envenoming causes challenges in prioritizing and ...
Sara Padidar
exaly +5 more sources
Indonesia as one of the largest tropical and agricultural countries in the world shared the particularly high burden cases of snakebite. In the last decade, World Health Organization (WHO) has listed snakebite as one of the neglected tropical disease ...
Randy Adiwinata, Erni J Nelwan
doaj +8 more sources
BackgroundPublished information on snakebite is rare in Bhutan although remarkably higher number of snakebites and associated deaths are reported from other South Asian countries.Aims and methodologyStructured questionnaire was used to collect knowledge ...
Sunil Sapkota +2 more
exaly +3 more sources
Repurposed small molecule toxin inhibitors neutralise a diversity of venoms from the Neotropical viperid snake genus Bothrops [PDF]
Snakebite globally claims more than 100,000 lives per year and results in morbidity for 400,000 survivors. Current treatment uses antibody-based antivenoms which are constrained by their efficacy, safety, and cost. In this study we evaluated the efficacy
Rachel H Clare +6 more
doaj +2 more sources
Estimating snakebite incidence from mathematical models: A test in Costa Rica
BackgroundSnakebite envenoming is a neglected public health challenge that affects mostly economically deprived communities who inhabit tropical regions.
Juan Cordovez +2 more
exaly +2 more sources
This was a cross-sectional study with the aim of characterising Naja nigricincta nigricincta’s oral bacterial flora as well as accompanying sensitivities and resistance towards antibiotics.
E Saaiman, C Buys, F Theart
doaj +1 more source
Antivenom is currently the first-choice treatment for snakebite envenoming. However, only a low proportion of antivenom immunoglobulins are specific to venom toxins, resulting in poor dose efficacy and potency.
Stefanie K. Menzies +9 more
doaj +1 more source
Wound infections following cytotoxic snakebites are common. Bites from Naja nigricincta nigricincta (an African spitting cobra) usually present as severe dermonecrosis spreading within the subdermal fascia layer.
EL Saaiman, PJ (Christo) Buys
doaj +1 more source
Snakebite is a neglected tropical disease that causes high rates of global mortality and morbidity. Although snakebite can cause a variety of pathologies in victims, haemotoxic effects are particularly common and are typically characterised by ...
Nessrin Alomran +11 more
doaj +1 more source
Key aims of the WHO Strategy to halve snakebite morbidity and mortality include health system strengthening and training of health workers. This requires knowledge of local health system needs and capacity, health worker training needs, and factors ...
Kieran Barnes +8 more
doaj +1 more source

